Treatment options for chronic prostatitis due to vancomycin-resistant Enterococcus faecium

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 11, 1998, Pages 798-800

  Taylor, S E ^a   Paterson, D L ^a   Yu, V L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; NITROFURANTOIN; RIFAMPICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CHRONIC PROSTATITIS; ENTEROCOCCUS FAECIUM; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CHRONIC DISEASE; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIVER TRANSPLANTATION; MALE; NITROFURANTOIN; PROSTATITIS; RIFAMPIN; URINE; VANCOMYCIN;

EID: 0032407172     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050190     Document Type: Article

References (14)

1. Morris JG, Shay DK, Hebden JN, McCarter RJ, Perdue BE, Jarvis W, Johnson JA, Dowling TC, Polish LB, Scwalbe RS: Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemnicity in a university medical center. Annals of Internal Medicine (1995) 123:250-259
2. Sobel JD, Kaye D: Urinary tract infections. In Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. Churchill Livingstone, New York (1995) pp. 662-690
3. Meares EM, Stamey TA: Bacteriologic localization patterns in bacterial prostatitis and urethritis. Investigations in Urology (1968) 5:492-518
4. Naber KG, Boerema JB, Bischoff W, Blenk H, Focht J, Carpenttier P, Sylvester J: An assessment of temafloxacin in the treatment of chronic bacterial prostatitis. Journal of Antimicrobrobial Chemotherapy (1991) 28, Supplement C: 87-96
5. Cox CE, Childs SJ: Treatment of chronic bacterial prostatitis with temafloxacin. American Journal of Medicine (1991) 91, Supplement 1:134-139
6. Borski AA, Pulaski EJ, Kimbrough JC, Fusillo MH: Prostatic fluid, semen and prostatic tissue concentrations of the major antibiotics following intravenous administration. Antibiotic Chemotherapy (1954) 4:905-910
7. Meares EM: Prostatitis: review of pharmacokinetics and therapy. Reviews of Infectious Diseases (1982) 4:475-483
8. Dunn BL, Stamey TA: Antibacterial concentrations in prostatic fluid. 1. Nitrofurantoin. Journal of Urology (1967) 97:505-507
9. Madsen PO, Wolf H, Barquin OP, Rhodes P: The nitrofurantoin concentration in prostatic fluid of humans and dogs. Journal of Urology (1968) 100:54-56
10. Giamarellou H, Kosmidis J, Leonidas M, Papadakis M, Daikos GK: A study of the effectiveness of rifaprim in chronic prostatitis caused mainly by Staphylococcus aureus. Journal of Urology (1982) 128:321-324
11. Kiuchi T, Tanaka K, Inomata Y, Uemoto S, Satomura K, Egawa H, Uyama S, Sano K, Okajina H, Yamaoka Y: Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects. Transplantation Proceedings (1996) 28:3171-3172
12. Prober CG: Effect of rifampin on chloramphenicol levels. New England Journal of Medicine (1985) 312:788
13. Chant C, Rybak MJ: Quinupristin/dalfopristin (RP 59500): a new streptogramin antibiotic. Annals of Pharmacotherapy (1995) 29:1022-1027
14. Hospital Infection Control Practices Advisory Committee: Recommendations for preventing the spread of vancomycin resistance. Infection Control and Hospital Epidemiology (1995) 16:105-113